GlassScriptPhysician profile
Scott Jit-Meng Lim
NPI 1376517151
$25,784.63
in general payments reported to CMS, 2019-2025
38 companies · $1,698 in 2025
The $1,698 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,026 · 2020: $5,105 · 2021: $1,665 · 2022: $2,977 · 2023: $7,539 · 2024: $3,776 · 2025: $1,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,038 · Travel and Lodging: $3,658 · Consulting Fee: $1,000 · Education: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,038.48 |
| Travel and Lodging | $3,658.23 |
| Consulting Fee | $1,000.00 |
| Education | $315.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,983.88 | 2021-2023 | |
| Abbott Laboratories | $4,689.30 | 2019-2024 | Mitraclip |
| Janssen Biotech, INC. | $1,722.57 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Abbvie INC. | $1,247.60 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $1,143.68 | 2023-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $1,118.02 | 2019-2025 | |
| Journey Medical Corporation | $978.73 | 2019-2025 | |
| Galderma Laboratories, L.P. | $884.42 | 2019-2025 | Nemluvio, Aklief, Twyneo |
| Pfizer INC. | $859.61 | 2019-2025 | |
| Genzyme Corporation | $823.47 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $717.82 | 2021-2025 | Sotyktu |
| Incyte Corporation | $710.30 | 2022-2025 | Opzelura, Opzelura |
| Biosense Webster, INC. | $699.39 | 2023-2024 | Carto 3 |
| Regeneron Healthcare Solutions, INC. | $689.86 | 2019-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $649.78 | 2019-2025 | Winlevi, Ilumya, Odomzo |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.